CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kovalev, S.
Right arrow Articles by Moll, U. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kovalev, S.
Right arrow Articles by Moll, U. M.

Cell Growth & Differentiation, Vol 9, Issue 11 897-903, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines

S Kovalev, N Marchenko, S Swendeman, M LaQuaglia and UM Moll
Department of Pathology, State University of New York at Stony Brook, 11794-8691, USA.

The novel p73 gene is a structural and, in overexpression systems, functional p53 homologue. p73 resides on chromosome 1p36.33 within a commonly deleted region in neuroblastoma (NB) and other human tumors. To evaluate p73's candidacy for a NB suppressor, we analyzed 28 primary NB tumors, 14 NB cell lines, and 5 non-NB malignant pediatric tumors. We determined the level of p73 expression and its allelic origin and searched for mutations. Fifty-one different types of normal tissues all showed very low p73 expression. Although most NB tumors expressed p73 within the normal tissue range, wild-type p73 expression levels varied widely in NB and non-NB tumors and NB cell lines with increases up to 90-fold compared with normal tissues. Importantly, the p73 gene was biallelically expressed in five of six NB tumors and three of three normal tissues. Mutation analysis of the entire open reading frame of the gene in 16 tumors (including all 6 highly expressing tumors) revealed four polymorphic sites, but no mutations. Collectively, our data argue that p73 is unlikely to be a suppressor gene inactivated during neuroblastoma development.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
K. Sabapathy
p73: a Positive or Negative Regulator of Angiogenesis, or Both?
Mol. Cell. Biol., March 15, 2016; 36(6): 848 - 854.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. Zhang, E. Xu, and X. Chen
TAp73 Protein Stability Is Controlled by Histone Deacetylase 1 via Regulation of Hsp90 Chaperone Function
J. Biol. Chem., March 15, 2013; 288(11): 7727 - 7737.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Coutandin, H. Der Ou, F. Lohr, and V. Dotsch
Tracing the protectors path from the germ line to the genome
PNAS, August 31, 2010; 107(35): 15318 - 15325.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
I. Dulloo and K. Sabapathy
Transactivation-dependent and -independent Regulation of p73 Stability
J. Biol. Chem., August 5, 2005; 280(31): 28203 - 28214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Marques, J. S. Horner, R. A. Ihrie, R. T. Bronson, and L. D. Attardi
Mice Lacking the p53/p63 Target Gene Perp Are Resistant to Papilloma Development
Cancer Res., August 1, 2005; 65(15): 6551 - 6556.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
W. H. Toh, S. Kyo, and K. Sabapathy
Relief of p53-mediated Telomerase Suppression by p73
J. Biol. Chem., April 29, 2005; 280(17): 17329 - 17338.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Flinterman, L. Guelen, S. Ezzati-Nik, R. Killick, G. Melino, K. Tominaga, J. S. Mymryk, J. Gaken, and M. Tavassoli
E1A Activates Transcription of p73 and Noxa to Induce Apoptosis
J. Biol. Chem., February 18, 2005; 280(7): 5945 - 5959.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Uramoto, K. Sugio, T. Oyama, S. Nakata, K. Ono, M. Morita, K. Funa, and K. Yasumoto
Expression of {Delta}Np73 Predicts Poor Prognosis in Lung Cancer
Clin. Cancer Res., October 15, 2004; 10(20): 6905 - 6911.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
U. M. Moll and N. Slade
p63 and p73: Roles in Development and Tumor Formation
Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. S. Liu, R. C.-Y. Leung, K. Y.-K. Chan, P.-M. Chiu, A. N.-Y. Cheung, K.-F. Tam, T.-Y. Ng, L.-C. Wong, and H. Y.-S. Ngan
p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy
Clin. Cancer Res., May 15, 2004; 10(10): 3309 - 3316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Concin, K. Becker, N. Slade, S. Erster, E. Mueller-Holzner, H. Ulmer, G. Daxenbichler, A. Zeimet, R. Zeillinger, C. Marth, et al.
Transdominant {Delta}TAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo
Cancer Res., April 1, 2004; 64(7): 2449 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
O. Petrenko, A. Zaika, and U. M. Moll
{Delta}Np73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation In Vivo
Mol. Cell. Biol., August 15, 2003; 23(16): 5540 - 5555.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Das, W. S. El-Deiry, and K. Somasundaram
Regulation of the p53 Homolog p73 by Adenoviral Oncogene E1A
J. Biol. Chem., May 16, 2003; 278(20): 18313 - 18320.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Stiewe, J. Stanelle, C. C. Theseling, B. Pollmeier, M. Beitzinger, and B. M. Putzer
Inactivation of Retinoblastoma (RB) Tumor Suppressor by Oncogenic Isoforms of the p53 Family Member p73
J. Biol. Chem., April 18, 2003; 278(16): 14230 - 14236.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
W. J. Freebern, J. L. Smith, S. S. Chaudhry, C. M. Haggerty, and K. Gardner
Novel Cell-specific and Dominant Negative Anti-apoptotic Roles of p73 in Transformed Leukemia Cells
J. Biol. Chem., January 24, 2003; 278(4): 2249 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. B. Davis, Y. Dong, and R. H. Weiss
Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Am J Physiol Cell Physiol, January 1, 2003; 284(1): C16 - C23.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Serber, H. C. Lai, A. Yang, H. D. Ou, M. S. Sigal, A. E. Kelly, B. D. Darimont, P. H. G. Duijf, H. van Bokhoven, F. McKeon, et al.
A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism
Mol. Cell. Biol., December 15, 2002; 22(24): 8601 - 8611.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. D. Hogarty, C. L. Winter, X. Liu, C. Guo, P. S. White, A. T. Look, G. M. Brodeur, and J. M. Maris
No Evidence for the Presence of an Imprinted Neuroblastoma Suppressor Gene within Chromosome Sub-Band 1p36.3
Cancer Res., November 15, 2002; 62(22): 6481 - 6484.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. I. Zaika, N. Slade, S. H. Erster, C. Sansome, T. W. Joseph, M. Pearl, E. Chalas, and U. M. Moll
{Delta}Np73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
J. Exp. Med., September 16, 2002; 196(6): 765 - 780.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Strano, G. Fontemaggi, A. Costanzo, M. G. Rizzo, O. Monti, A. Baccarini, G. Del Sal, M. Levrero, A. Sacchi, M. Oren, et al.
Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities
J. Biol. Chem., May 24, 2002; 277(21): 18817 - 18826.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Stiewe, C. C. Theseling, and B. M. Putzer
Transactivation-deficient {Delta}TA-p73 Inhibits p53 by Direct Competition for DNA Binding: IMPLICATIONS FOR TUMORIGENESIS
J. Biol. Chem., April 19, 2002; 277(16): 14177 - 14185.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X.-F. Sun
p73 Overexpression Is a Prognostic Factor in Patients with Colorectal Adenocarcinoma
Clin. Cancer Res., January 1, 2002; 8(1): 165 - 170.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Zaika, M. Irwin, C. Sansome, and U. M. Moll
Oncogenes Induce and Activate Endogenous p73 Protein
J. Biol. Chem., April 6, 2001; 276(14): 11310 - 11316.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives
A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain
Mol. Cell. Biol., March 1, 2001; 21(5): 1874 - 1887.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. A. Brooks, J. A. Tidy, B. Gusterson, L. Hiller, J. O'Nions, M. Gasco, M. C. Marin, P. J. Farrell, W. G. Kaelin Jr., and T. Crook
Preferential Retention of Codon 72 Arginine p53 in Squamous Cell Carcinomas of the Vulva Occurs in Cancers Positive and Negative for Human Papillomavirus
Cancer Res., December 1, 2000; 60(24): 6875 - 6877.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
M. Levrero, V. De Laurenzi, A. Costanzo, J. Gong, J. Y. Wang, and G. Melino
The p53/p63/p73 family of transcription factors: overlapping and distinct functions
J. Cell Sci., May 15, 2000; 113(10): 1661 - 1670.
[Abstract] [PDF]


Home page
Cancer Res.Home page
W. A. Weiss, T. Godfrey, C. Francisco, and J. M. Bishop
Genome-wide Screen for Allelic Imbalance in a Mouse Model for Neuroblastoma
Cancer Res., May 1, 2000; 60(9): 2483 - 2487.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. I. Zaika, S. Kovalev, N. D. Marchenko, and U. M. Moll
Overexpression of the Wild Type p73 Gene in Breast Cancer Tissues and Cell Lines
Cancer Res., July 1, 1999; 59(13): 3257 - 3263.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. G. Corn, S. J. Kuerbitz, M. M. van Noesel, M. Esteller, N. Compitello, S. B. Baylin, and J. G. Herman
Transcriptional Silencing of the p73 Gene in Acute Lymphoblastic Leukemia and Burkitt's Lymphoma Is Associated with 5' CpG Island Methylation
Cancer Res., July 1, 1999; 59(14): 3352 - 3356.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Shimada, S. Kato, K. Enjo, M. Osada, Y. Ikawa, K. Kohno, M. Obinata, R. Kanamaru, S. Ikawa, and C. Ishioka
The Transcriptional Activities of p53 and Its Homologue p51/p63: Similaritiesand Differences
Cancer Res., June 1, 1999; 59(12): 2781 - 2786.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-G. Chi, S.-G. Chang, S.-J. Lee, C.-H. Lee, J. I. Kim, and J.-H. Park
Elevated and Biallelic Expression of p73 Is Associated with Progression of Human Bladder Cancer
Cancer Res., June 1, 1999; 59(12): 2791 - 2793.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Zeng, L. Chen, C. A. Jost, R. Maya, D. Keller, X. Wang, W. G. Kaelin Jr., M. Oren, J. Chen, and H. Lu
MDM2 Suppresses p73 Function without Promoting p73 Degradation
Mol. Cell. Biol., May 1, 1999; 19(5): 3257 - 3266.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Zaika, M. Irwin, C. Sansome, and U. M. Moll
Oncogenes Induce and Activate Endogenous p73 Protein
J. Biol. Chem., April 6, 2001; 276(14): 11310 - 11316.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.